GSA Capital Partners’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-4,670
| Closed | -$250K | – | 2103 |
|
|
2016
Q1 | $250K | Buy |
4,670
+1,353
| +41% | +$72.4K | 0.02% | 1394 |
|
|
2015
Q4 | $375K | Sell |
3,317
-20,455
| -86% | -$2.31M | 0.02% | 1337 |
|
|
2015
Q3 | $2.8M | Buy |
23,772
+15,806
| +198% | +$1.86M | 0.14% | 139 |
|
|
2015
Q2 | $617K | Buy |
+7,966
| New | +$617K | 0.02% | 1218 |
|
|
2015
Q1 | – | Sell |
-6,905
| Closed | -$223K | – | 2374 |
|
|
2014
Q4 | $223K | Sell |
6,905
-11,471
| -62% | -$370K | 0.02% | 1418 |
|
|
2014
Q3 | $450K | Buy |
18,376
+6,400
| +53% | +$157K | 0.02% | 1000 |
|
|
2014
Q2 | $212K | Buy |
+11,976
| New | +$212K | 0.01% | 1597 |
|
|
2014
Q1 | – | Sell |
-10,918
| Closed | -$183K | – | 2048 |
|
|
2013
Q4 | $183K | Buy |
+10,918
| New | +$183K | 0.01% | 1484 |
|